Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.

Influenza A can be complicated by secondary bacterial pneumonia, which is most frequently caused by Streptococcus pneumoniae and associated with uncontrolled pulmonary inflammation. Evidence points to Toll-like receptor (TLR) 2 as a possible mediator of this exaggerated lung inflammation: (1) TLR2 is the most important "sensor" for gram-positive stimuli, (2) TLR2 contributes to S. pneumoniae-induced inflammation, and (3) influenza A enhances TLR2 expression in various cell types. Therefore, the objective of this study was to determine the role of TLR2 in the host response to postinfluenza pneumococcal pneumonia. TLR2 knockout (KO) and wild-type (WT) mice were infected intranasally with influenza A virus. Fourteen days later they were administered with S. pneumoniae intranasally. Influenza was associated with a similar transient weight loss in TLR2 KO and WT mice. Both mouse strains were fully recovered and had completely cleared the virus at Day 14. Importantly, no differences between TLR2 KO and WT mice were detected during postinfluenza pneumococcal pneumonia with respect to bacterial growth, lung inflammation, or cytokine/chemokine concentrations, with the exception of lower pulmonary levels of cytokine-induced neutrophil chemoattractant in TLR2 KO mice. Toll-like receptor 2 does not contribute to host defense during murine postinfluenza pneumococcal pneumonia.

[1]  S. Akira,et al.  Toll‐like receptor 9 acts at an early stage in host defence against pneumococcal infection , 2007, Cellular microbiology.

[2]  Lena Alexopoulou,et al.  Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia , 2006, PLoS pathogens.

[3]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[4]  T. Mitchell,et al.  Innate immunity and the pneumococcus. , 2006, Microbiology.

[5]  K. Hartshorn,et al.  Influenza A Viruses Upregulate Neutrophil Toll‐Like Receptor 2 Expression and Function , 2006, Scandinavian journal of immunology.

[6]  Shizuo Akira,et al.  Innate immune recognition of viral infection , 2006, Nature Immunology.

[7]  T. van der Poll,et al.  Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. , 2006, The Journal of infectious diseases.

[8]  T. van der Poll,et al.  Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[9]  M. Hornef,et al.  Myeloid differentiation factor 88‐dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice , 2005, Cellular microbiology.

[10]  S. Akira,et al.  The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung1 , 2005, The Journal of Immunology.

[11]  M. Levin,et al.  Varicella-Zoster Virus Activates Inflammatory Cytokines in Human Monocytes and Macrophages via Toll-Like Receptor 2 , 2005, Journal of Virology.

[12]  Rajagopal N. Aravalli,et al.  Cutting Edge: TLR2-Mediated Proinflammatory Cytokine and Chemokine Production by Microglial Cells in Response to Herpes Simplex Virus1 , 2005, The Journal of Immunology.

[13]  M. Netea,et al.  From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias , 2005, Antimicrobial Agents and Chemotherapy.

[14]  J. P. Long,et al.  Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. , 2004, Microbial pathogenesis.

[15]  N. Reiling,et al.  CD14 is required for influenza A virus-induced cytokine and chemokine production. , 2004, Immunobiology.

[16]  T. van der Poll,et al.  IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.

[17]  S. Akira,et al.  Toll-Like Receptor 2 Plays a Role in the Early Inflammatory Response to Murine Pneumococcal Pneumonia but Does Not Contribute to Antibacterial Defense1 , 2004, The Journal of Immunology.

[18]  R. Bronson,et al.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. van der Poll,et al.  Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice , 2004, Infection and Immunity.

[20]  D. Golenbock,et al.  Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2 , 2003, Journal of Virology.

[21]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. van der Poll,et al.  Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. , 2003, American journal of respiratory and critical care medicine.

[23]  H. Wagner,et al.  Toll-Like Receptor 2 Participates in Mediation of Immune Response in Experimental Pneumococcal Meningitis1 , 2003, The Journal of Immunology.

[24]  K. Frei,et al.  Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.

[25]  T. van der Poll,et al.  TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia1 , 2001, The Journal of Immunology.

[26]  I. Julkunen,et al.  IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.

[27]  P. Schipper,et al.  Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR , 2001, Journal of Clinical Microbiology.

[28]  S. Akira,et al.  Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.

[29]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  K. O'Brien,et al.  Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[32]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[33]  L. Simonsen,et al.  The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.

[34]  L. Leon,et al.  Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. , 1997, The American journal of physiology.

[35]  T. van der Poll,et al.  Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. , 1997, American journal of respiratory and critical care medicine.

[36]  T. van der Poll,et al.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.

[37]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[38]  J. Enders,et al.  Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.